Factors Associated with the Immunogenicity of Anti-Tumor Necrosis Factor Agents in Pediatric Patients with Inflammatory Bowel Disease

BACKGROUND/AIMS: Anti-drug antibodies (ADAs) can develop during treatment with anti-tumor necrosis factor (TNF) agents. We aimed to investigate the factors associated with immunogenicity of anti-TNF agents in pediatric patients with inflammatory bowel disease (IBD) and observe the clinical course of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ju Young, Lee, Yoon, Choe, Byung-Ho, Kang, Ben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283299/
https://www.ncbi.nlm.nih.gov/pubmed/33024062
http://dx.doi.org/10.5009/gnl20134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283299/
https://www.ncbi.nlm.nih.gov/pubmed/33024062
http://dx.doi.org/10.5009/gnl20134

Ejemplares similares